nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—epilepsy syndrome	0.144	0.454	CbGaD
Apixaban—CYP2C19—epilepsy syndrome	0.113	0.357	CbGaD
Apixaban—ABCB1—epilepsy syndrome	0.06	0.189	CbGaD
Apixaban—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0168	0.033	CbGbCtD
Apixaban—CYP2C8—Trimethadione—epilepsy syndrome	0.015	0.0295	CbGbCtD
Apixaban—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0141	0.0277	CbGbCtD
Apixaban—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0136	0.0266	CbGbCtD
Apixaban—CYP2C19—Felbamate—epilepsy syndrome	0.0126	0.0247	CbGbCtD
Apixaban—CYP2C19—Trimethadione—epilepsy syndrome	0.0126	0.0247	CbGbCtD
Apixaban—ABCB1—Levetiracetam—epilepsy syndrome	0.012	0.0235	CbGbCtD
Apixaban—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0118	0.0233	CbGbCtD
Apixaban—CYP3A5—Carbamazepine—epilepsy syndrome	0.0106	0.0207	CbGbCtD
Apixaban—CYP2C9—Trimethadione—epilepsy syndrome	0.0105	0.0206	CbGbCtD
Apixaban—CYP2C19—Clobazam—epilepsy syndrome	0.0103	0.0202	CbGbCtD
Apixaban—CYP2C8—Carbamazepine—epilepsy syndrome	0.0101	0.0199	CbGbCtD
Apixaban—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00985	0.0193	CbGbCtD
Apixaban—CYP2C8—Primidone—epilepsy syndrome	0.00947	0.0186	CbGbCtD
Apixaban—CYP3A5—Phenytoin—epilepsy syndrome	0.00946	0.0186	CbGbCtD
Apixaban—CYP2C8—Phenytoin—epilepsy syndrome	0.0091	0.0179	CbGbCtD
Apixaban—CYP2C19—Carbamazepine—epilepsy syndrome	0.00851	0.0167	CbGbCtD
Apixaban—CYP2C8—Propofol—epilepsy syndrome	0.00849	0.0167	CbGbCtD
Apixaban—CYP3A5—Phenobarbital—epilepsy syndrome	0.00843	0.0166	CbGbCtD
Apixaban—CYP3A5—Midazolam—epilepsy syndrome	0.00832	0.0163	CbGbCtD
Apixaban—ABCB1—Clobazam—epilepsy syndrome	0.00829	0.0163	CbGbCtD
Apixaban—CYP2C8—Phenobarbital—epilepsy syndrome	0.00811	0.0159	CbGbCtD
Apixaban—CYP3A5—Diazepam—epilepsy syndrome	0.008	0.0157	CbGbCtD
Apixaban—ABCB1—Lamotrigine—epilepsy syndrome	0.00798	0.0157	CbGbCtD
Apixaban—CYP2C19—Primidone—epilepsy syndrome	0.00795	0.0156	CbGbCtD
Apixaban—CYP1A2—Carbamazepine—epilepsy syndrome	0.00785	0.0154	CbGbCtD
Apixaban—CYP2C8—Diazepam—epilepsy syndrome	0.00769	0.0151	CbGbCtD
Apixaban—CYP2C19—Phenytoin—epilepsy syndrome	0.00763	0.015	CbGbCtD
Apixaban—CYP1A2—Primidone—epilepsy syndrome	0.00733	0.0144	CbGbCtD
Apixaban—CYP2C19—Propofol—epilepsy syndrome	0.00712	0.014	CbGbCtD
Apixaban—CYP2C9—Carbamazepine—epilepsy syndrome	0.00708	0.0139	CbGbCtD
Apixaban—ABCB1—Carbamazepine—epilepsy syndrome	0.00687	0.0135	CbGbCtD
Apixaban—CYP2C19—Phenobarbital—epilepsy syndrome	0.0068	0.0134	CbGbCtD
Apixaban—CYP2C9—Primidone—epilepsy syndrome	0.00661	0.013	CbGbCtD
Apixaban—CYP1A2—Propofol—epilepsy syndrome	0.00657	0.0129	CbGbCtD
Apixaban—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00655	0.0129	CbGbCtD
Apixaban—CYP2C19—Diazepam—epilepsy syndrome	0.00645	0.0127	CbGbCtD
Apixaban—CYP2C9—Phenytoin—epilepsy syndrome	0.00635	0.0125	CbGbCtD
Apixaban—CYP3A5—Valproic Acid—epilepsy syndrome	0.0063	0.0124	CbGbCtD
Apixaban—CYP2C19—Zonisamide—epilepsy syndrome	0.0063	0.0124	CbGbCtD
Apixaban—CYP1A2—Phenobarbital—epilepsy syndrome	0.00628	0.0123	CbGbCtD
Apixaban—ABCB1—Phenytoin—epilepsy syndrome	0.00616	0.0121	CbGbCtD
Apixaban—CYP3A4—Trimethadione—epilepsy syndrome	0.00609	0.012	CbGbCtD
Apixaban—CYP3A4—Felbamate—epilepsy syndrome	0.00609	0.012	CbGbCtD
Apixaban—CYP2C8—Valproic Acid—epilepsy syndrome	0.00606	0.0119	CbGbCtD
Apixaban—CYP1A2—Diazepam—epilepsy syndrome	0.00595	0.0117	CbGbCtD
Apixaban—CYP2C9—Propofol—epilepsy syndrome	0.00592	0.0116	CbGbCtD
Apixaban—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00573	0.0112	CbGbCtD
Apixaban—CYP2C9—Phenobarbital—epilepsy syndrome	0.00566	0.0111	CbGbCtD
Apixaban—ABCB1—Phenobarbital—epilepsy syndrome	0.00549	0.0108	CbGbCtD
Apixaban—ABCB1—Midazolam—epilepsy syndrome	0.00541	0.0106	CbGbCtD
Apixaban—CYP2C9—Diazepam—epilepsy syndrome	0.00536	0.0105	CbGbCtD
Apixaban—ABCB1—Diazepam—epilepsy syndrome	0.0052	0.0102	CbGbCtD
Apixaban—CYP3A4—Clonazepam—epilepsy syndrome	0.00518	0.0102	CbGbCtD
Apixaban—CYP2C19—Valproic Acid—epilepsy syndrome	0.00508	0.00998	CbGbCtD
Apixaban—CYP3A4—Clobazam—epilepsy syndrome	0.00497	0.00975	CbGbCtD
Apixaban—CYP1A2—Valproic Acid—epilepsy syndrome	0.00469	0.00921	CbGbCtD
Apixaban—CYP2C19—Topiramate—epilepsy syndrome	0.00459	0.009	CbGbCtD
Apixaban—CYP2C9—Valproic Acid—epilepsy syndrome	0.00423	0.0083	CbGbCtD
Apixaban—CYP3A4—Rufinamide—epilepsy syndrome	0.00422	0.00829	CbGbCtD
Apixaban—CYP3A4—Carbamazepine—epilepsy syndrome	0.00411	0.00808	CbGbCtD
Apixaban—CYP3A4—Primidone—epilepsy syndrome	0.00384	0.00754	CbGbCtD
Apixaban—CYP3A4—Phenytoin—epilepsy syndrome	0.00369	0.00724	CbGbCtD
Apixaban—CYP3A4—Propofol—epilepsy syndrome	0.00344	0.00676	CbGbCtD
Apixaban—CYP3A4—Acetazolamide—epilepsy syndrome	0.00329	0.00646	CbGbCtD
Apixaban—CYP3A4—Phenobarbital—epilepsy syndrome	0.00329	0.00646	CbGbCtD
Apixaban—CYP3A4—Midazolam—epilepsy syndrome	0.00324	0.00637	CbGbCtD
Apixaban—CYP3A4—Diazepam—epilepsy syndrome	0.00312	0.00612	CbGbCtD
Apixaban—CYP3A4—Zonisamide—epilepsy syndrome	0.00304	0.00597	CbGbCtD
Apixaban—CYP3A4—Valproic Acid—epilepsy syndrome	0.00246	0.00482	CbGbCtD
Apixaban—CYP3A4—Topiramate—epilepsy syndrome	0.00222	0.00435	CbGbCtD
Apixaban—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000137	0.00113	CcSEcCtD
Apixaban—Syncope—Oxcarbazepine—epilepsy syndrome	0.000136	0.00112	CcSEcCtD
Apixaban—Skin disorder—Vigabatrin—epilepsy syndrome	0.000136	0.00112	CcSEcCtD
Apixaban—Hepatobiliary disease—Valproic Acid—epilepsy syndrome	0.000136	0.00111	CcSEcCtD
Apixaban—Shock—Diazepam—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Epistaxis—Valproic Acid—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Nervous system disorder—Diazepam—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Anaemia—Carbamazepine—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Dizziness—Rufinamide—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Thrombocytopenia—Diazepam—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
Apixaban—Loss of consciousness—Phenytoin—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
Apixaban—Hypotension—Fosphenytoin—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
Apixaban—Loss of consciousness—Oxcarbazepine—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
Apixaban—Skin disorder—Diazepam—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
Apixaban—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000133	0.00109	CcSEcCtD
Apixaban—Rash—Phenobarbital—epilepsy syndrome	0.000131	0.00108	CcSEcCtD
Apixaban—Syncope—Carbamazepine—epilepsy syndrome	0.000131	0.00108	CcSEcCtD
Apixaban—Dermatitis—Phenobarbital—epilepsy syndrome	0.000131	0.00107	CcSEcCtD
Apixaban—Thrombocytopenia—Felbamate—epilepsy syndrome	0.00013	0.00107	CcSEcCtD
Apixaban—Anaemia—Lamotrigine—epilepsy syndrome	0.00013	0.00107	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.00013	0.00107	CcSEcCtD
Apixaban—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.00013	0.00107	CcSEcCtD
Apixaban—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000129	0.00106	CcSEcCtD
Apixaban—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000129	0.00106	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000129	0.00106	CcSEcCtD
Apixaban—Hypotension—Diazepam—epilepsy syndrome	0.000129	0.00106	CcSEcCtD
Apixaban—Rash—Rufinamide—epilepsy syndrome	0.000128	0.00106	CcSEcCtD
Apixaban—Dermatitis—Rufinamide—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Loss of consciousness—Carbamazepine—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Shock—Zonisamide—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Apixaban—Urinary tract disorder—Valproic Acid—epilepsy syndrome	0.000127	0.00104	CcSEcCtD
Apixaban—Skin disorder—Zonisamide—epilepsy syndrome	0.000127	0.00104	CcSEcCtD
Apixaban—Dizziness—Lacosamide—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Apixaban—Connective tissue disorder—Valproic Acid—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Apixaban—Syncope—Lamotrigine—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Apixaban—Urethral disorder—Valproic Acid—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Apixaban—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000126	0.00103	CcSEcCtD
Apixaban—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000125	0.00103	CcSEcCtD
Apixaban—Hypotension—Felbamate—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Apixaban—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Apixaban—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Apixaban—Haematuria—Pregabalin—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Nausea—Phenobarbital—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Dizziness—Clobazam—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Shock—Phenytoin—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Apixaban—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000122	0.00101	CcSEcCtD
Apixaban—Epistaxis—Pregabalin—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Shock—Oxcarbazepine—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Skin disorder—Clonazepam—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Hypotension—Zonisamide—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Apixaban—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000121	0.000998	CcSEcCtD
Apixaban—Nausea—Rufinamide—epilepsy syndrome	0.000121	0.000995	CcSEcCtD
Apixaban—Rash—Lacosamide—epilepsy syndrome	0.000121	0.000991	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000121	0.000991	CcSEcCtD
Apixaban—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000121	0.000991	CcSEcCtD
Apixaban—Dermatitis—Lacosamide—epilepsy syndrome	0.00012	0.00099	CcSEcCtD
Apixaban—Eye disorder—Valproic Acid—epilepsy syndrome	0.00012	0.000989	CcSEcCtD
Apixaban—Liver function test abnormal—Topiramate—epilepsy syndrome	0.00012	0.000985	CcSEcCtD
Apixaban—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000119	0.000979	CcSEcCtD
Apixaban—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000119	0.000976	CcSEcCtD
Apixaban—Hypotension—Clonazepam—epilepsy syndrome	0.000117	0.000964	CcSEcCtD
Apixaban—Breast disorder—Topiramate—epilepsy syndrome	0.000117	0.000964	CcSEcCtD
Apixaban—Shock—Carbamazepine—epilepsy syndrome	0.000117	0.000963	CcSEcCtD
Apixaban—Rash—Clobazam—epilepsy syndrome	0.000117	0.000962	CcSEcCtD
Apixaban—Dermatitis—Clobazam—epilepsy syndrome	0.000117	0.000961	CcSEcCtD
Apixaban—Haemoglobin—Pregabalin—epilepsy syndrome	0.000117	0.000961	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Topiramate—epilepsy syndrome	0.000117	0.00096	CcSEcCtD
Apixaban—Angiopathy—Valproic Acid—epilepsy syndrome	0.000117	0.00096	CcSEcCtD
Apixaban—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000117	0.00096	CcSEcCtD
Apixaban—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000117	0.000958	CcSEcCtD
Apixaban—Hypotension—Phenytoin—epilepsy syndrome	0.000117	0.000958	CcSEcCtD
Apixaban—Haemorrhage—Pregabalin—epilepsy syndrome	0.000116	0.000956	CcSEcCtD
Apixaban—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000116	0.000955	CcSEcCtD
Apixaban—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000116	0.000953	CcSEcCtD
Apixaban—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000116	0.000953	CcSEcCtD
Apixaban—Skin disorder—Carbamazepine—epilepsy syndrome	0.000116	0.000951	CcSEcCtD
Apixaban—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000115	0.000944	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.000114	0.000941	CcSEcCtD
Apixaban—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.000114	0.00094	CcSEcCtD
Apixaban—Urethral disorder—Pregabalin—epilepsy syndrome	0.000114	0.000937	CcSEcCtD
Apixaban—Nausea—Lacosamide—epilepsy syndrome	0.000114	0.000934	CcSEcCtD
Apixaban—Haematuria—Gabapentin—epilepsy syndrome	0.000113	0.000931	CcSEcCtD
Apixaban—Shock—Lamotrigine—epilepsy syndrome	0.000113	0.00093	CcSEcCtD
Apixaban—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000113	0.000928	CcSEcCtD
Apixaban—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000113	0.000926	CcSEcCtD
Apixaban—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000112	0.000925	CcSEcCtD
Apixaban—Hepatobiliary disease—Gabapentin—epilepsy syndrome	0.000112	0.000924	CcSEcCtD
Apixaban—Epistaxis—Gabapentin—epilepsy syndrome	0.000112	0.000921	CcSEcCtD
Apixaban—Hypotension—Carbamazepine—epilepsy syndrome	0.000111	0.000914	CcSEcCtD
Apixaban—Hypersensitivity—Midazolam—epilepsy syndrome	0.000111	0.000911	CcSEcCtD
Apixaban—Nausea—Clobazam—epilepsy syndrome	0.00011	0.000906	CcSEcCtD
Apixaban—Dizziness—Acetazolamide—epilepsy syndrome	0.000109	0.000899	CcSEcCtD
Apixaban—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000109	0.000899	CcSEcCtD
Apixaban—Eye disorder—Pregabalin—epilepsy syndrome	0.000109	0.000894	CcSEcCtD
Apixaban—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000108	0.000891	CcSEcCtD
Apixaban—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000108	0.000885	CcSEcCtD
Apixaban—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000107	0.00088	CcSEcCtD
Apixaban—Haemorrhage—Gabapentin—epilepsy syndrome	0.000107	0.000877	CcSEcCtD
Apixaban—Angiopathy—Pregabalin—epilepsy syndrome	0.000106	0.000868	CcSEcCtD
Apixaban—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000105	0.000866	CcSEcCtD
Apixaban—Immune system disorder—Pregabalin—epilepsy syndrome	0.000105	0.000864	CcSEcCtD
Apixaban—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000105	0.000862	CcSEcCtD
Apixaban—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000105	0.000862	CcSEcCtD
Apixaban—Urethral disorder—Gabapentin—epilepsy syndrome	0.000105	0.00086	CcSEcCtD
Apixaban—Anaemia—Valproic Acid—epilepsy syndrome	0.000104	0.000851	CcSEcCtD
Apixaban—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000103	0.000846	CcSEcCtD
Apixaban—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000103	0.000845	CcSEcCtD
Apixaban—Dizziness—Propofol—epilepsy syndrome	0.000102	0.000835	CcSEcCtD
Apixaban—Hypersensitivity—Diazepam—epilepsy syndrome	0.000101	0.000833	CcSEcCtD
Apixaban—Eye disorder—Gabapentin—epilepsy syndrome	9.97e-05	0.00082	CcSEcCtD
Apixaban—Dizziness—Midazolam—epilepsy syndrome	9.94e-05	0.000817	CcSEcCtD
Apixaban—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	9.93e-05	0.000817	CcSEcCtD
Apixaban—Nausea—Acetazolamide—epilepsy syndrome	9.83e-05	0.000808	CcSEcCtD
Apixaban—Dizziness—Levetiracetam—epilepsy syndrome	9.82e-05	0.000807	CcSEcCtD
Apixaban—Rash—Propofol—epilepsy syndrome	9.69e-05	0.000797	CcSEcCtD
Apixaban—Dermatitis—Propofol—epilepsy syndrome	9.68e-05	0.000796	CcSEcCtD
Apixaban—Immune system disorder—Gabapentin—epilepsy syndrome	9.64e-05	0.000792	CcSEcCtD
Apixaban—Mediastinal disorder—Gabapentin—epilepsy syndrome	9.62e-05	0.00079	CcSEcCtD
Apixaban—Hypersensitivity—Zonisamide—epilepsy syndrome	9.6e-05	0.000789	CcSEcCtD
Apixaban—Haematuria—Topiramate—epilepsy syndrome	9.53e-05	0.000784	CcSEcCtD
Apixaban—Rash—Midazolam—epilepsy syndrome	9.48e-05	0.000779	CcSEcCtD
Apixaban—Dizziness—Fosphenytoin—epilepsy syndrome	9.48e-05	0.000779	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	9.47e-05	0.000779	CcSEcCtD
Apixaban—Dermatitis—Midazolam—epilepsy syndrome	9.47e-05	0.000779	CcSEcCtD
Apixaban—Epistaxis—Topiramate—epilepsy syndrome	9.43e-05	0.000775	CcSEcCtD
Apixaban—Rash—Levetiracetam—epilepsy syndrome	9.36e-05	0.00077	CcSEcCtD
Apixaban—Anaemia—Pregabalin—epilepsy syndrome	9.36e-05	0.000769	CcSEcCtD
Apixaban—Dermatitis—Levetiracetam—epilepsy syndrome	9.35e-05	0.000769	CcSEcCtD
Apixaban—Hypersensitivity—Clonazepam—epilepsy syndrome	9.25e-05	0.00076	CcSEcCtD
Apixaban—Dizziness—Vigabatrin—epilepsy syndrome	9.24e-05	0.000759	CcSEcCtD
Apixaban—Hypersensitivity—Phenytoin—epilepsy syndrome	9.19e-05	0.000755	CcSEcCtD
Apixaban—Anaphylactic shock—Valproic Acid—epilepsy syndrome	9.14e-05	0.000752	CcSEcCtD
Apixaban—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.14e-05	0.000751	CcSEcCtD
Apixaban—Nausea—Propofol—epilepsy syndrome	9.13e-05	0.00075	CcSEcCtD
Apixaban—Dizziness—Diazepam—epilepsy syndrome	9.09e-05	0.000748	CcSEcCtD
Apixaban—Syncope—Pregabalin—epilepsy syndrome	9.08e-05	0.000747	CcSEcCtD
Apixaban—Rash—Fosphenytoin—epilepsy syndrome	9.04e-05	0.000743	CcSEcCtD
Apixaban—Dermatitis—Fosphenytoin—epilepsy syndrome	9.03e-05	0.000742	CcSEcCtD
Apixaban—Haemoglobin—Topiramate—epilepsy syndrome	9.02e-05	0.000742	CcSEcCtD
Apixaban—Haemorrhage—Topiramate—epilepsy syndrome	8.98e-05	0.000738	CcSEcCtD
Apixaban—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.97e-05	0.000737	CcSEcCtD
Apixaban—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.95e-05	0.000736	CcSEcCtD
Apixaban—Nausea—Midazolam—epilepsy syndrome	8.93e-05	0.000734	CcSEcCtD
Apixaban—Loss of consciousness—Pregabalin—epilepsy syndrome	8.9e-05	0.000732	CcSEcCtD
Apixaban—Skin disorder—Valproic Acid—epilepsy syndrome	8.88e-05	0.00073	CcSEcCtD
Apixaban—Urinary tract disorder—Topiramate—epilepsy syndrome	8.86e-05	0.000729	CcSEcCtD
Apixaban—Connective tissue disorder—Topiramate—epilepsy syndrome	8.82e-05	0.000725	CcSEcCtD
Apixaban—Nausea—Levetiracetam—epilepsy syndrome	8.82e-05	0.000725	CcSEcCtD
Apixaban—Rash—Vigabatrin—epilepsy syndrome	8.81e-05	0.000724	CcSEcCtD
Apixaban—Dizziness—Felbamate—epilepsy syndrome	8.8e-05	0.000723	CcSEcCtD
Apixaban—Dermatitis—Vigabatrin—epilepsy syndrome	8.8e-05	0.000723	CcSEcCtD
Apixaban—Urethral disorder—Topiramate—epilepsy syndrome	8.8e-05	0.000723	CcSEcCtD
Apixaban—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.77e-05	0.000721	CcSEcCtD
Apixaban—Rash—Diazepam—epilepsy syndrome	8.67e-05	0.000713	CcSEcCtD
Apixaban—Dermatitis—Diazepam—epilepsy syndrome	8.66e-05	0.000712	CcSEcCtD
Apixaban—Dizziness—Zonisamide—epilepsy syndrome	8.62e-05	0.000708	CcSEcCtD
Apixaban—Anaemia—Gabapentin—epilepsy syndrome	8.58e-05	0.000706	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.56e-05	0.000704	CcSEcCtD
Apixaban—Hypotension—Valproic Acid—epilepsy syndrome	8.54e-05	0.000702	CcSEcCtD
Apixaban—Nausea—Fosphenytoin—epilepsy syndrome	8.51e-05	0.0007	CcSEcCtD
Apixaban—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.48e-05	0.000697	CcSEcCtD
Apixaban—Rash—Felbamate—epilepsy syndrome	8.39e-05	0.00069	CcSEcCtD
Apixaban—Eye disorder—Topiramate—epilepsy syndrome	8.39e-05	0.000689	CcSEcCtD
Apixaban—Dermatitis—Felbamate—epilepsy syndrome	8.38e-05	0.000689	CcSEcCtD
Apixaban—Syncope—Gabapentin—epilepsy syndrome	8.33e-05	0.000685	CcSEcCtD
Apixaban—Dizziness—Clonazepam—epilepsy syndrome	8.3e-05	0.000683	CcSEcCtD
Apixaban—Nausea—Vigabatrin—epilepsy syndrome	8.3e-05	0.000682	CcSEcCtD
Apixaban—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.27e-05	0.000679	CcSEcCtD
Apixaban—Dizziness—Phenytoin—epilepsy syndrome	8.25e-05	0.000678	CcSEcCtD
Apixaban—Rash—Zonisamide—epilepsy syndrome	8.21e-05	0.000675	CcSEcCtD
Apixaban—Dermatitis—Zonisamide—epilepsy syndrome	8.21e-05	0.000675	CcSEcCtD
Apixaban—Dizziness—Oxcarbazepine—epilepsy syndrome	8.2e-05	0.000674	CcSEcCtD
Apixaban—Nausea—Diazepam—epilepsy syndrome	8.17e-05	0.000671	CcSEcCtD
Apixaban—Loss of consciousness—Gabapentin—epilepsy syndrome	8.16e-05	0.000671	CcSEcCtD
Apixaban—Angiopathy—Topiramate—epilepsy syndrome	8.14e-05	0.000669	CcSEcCtD
Apixaban—Shock—Pregabalin—epilepsy syndrome	8.13e-05	0.000668	CcSEcCtD
Apixaban—Immune system disorder—Topiramate—epilepsy syndrome	8.11e-05	0.000666	CcSEcCtD
Apixaban—Nervous system disorder—Pregabalin—epilepsy syndrome	8.11e-05	0.000666	CcSEcCtD
Apixaban—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.09e-05	0.000665	CcSEcCtD
Apixaban—Mediastinal disorder—Topiramate—epilepsy syndrome	8.09e-05	0.000665	CcSEcCtD
Apixaban—Skin disorder—Pregabalin—epilepsy syndrome	8.03e-05	0.00066	CcSEcCtD
Apixaban—Rash—Clonazepam—epilepsy syndrome	7.92e-05	0.000651	CcSEcCtD
Apixaban—Dermatitis—Clonazepam—epilepsy syndrome	7.91e-05	0.00065	CcSEcCtD
Apixaban—Nausea—Felbamate—epilepsy syndrome	7.91e-05	0.00065	CcSEcCtD
Apixaban—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.89e-05	0.000649	CcSEcCtD
Apixaban—Dizziness—Carbamazepine—epilepsy syndrome	7.87e-05	0.000647	CcSEcCtD
Apixaban—Rash—Phenytoin—epilepsy syndrome	7.86e-05	0.000646	CcSEcCtD
Apixaban—Dermatitis—Phenytoin—epilepsy syndrome	7.86e-05	0.000646	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.85e-05	0.000645	CcSEcCtD
Apixaban—Rash—Oxcarbazepine—epilepsy syndrome	7.82e-05	0.000643	CcSEcCtD
Apixaban—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.82e-05	0.000642	CcSEcCtD
Apixaban—Nausea—Zonisamide—epilepsy syndrome	7.74e-05	0.000636	CcSEcCtD
Apixaban—Hypotension—Pregabalin—epilepsy syndrome	7.72e-05	0.000635	CcSEcCtD
Apixaban—Dizziness—Lamotrigine—epilepsy syndrome	7.61e-05	0.000625	CcSEcCtD
Apixaban—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.58e-05	0.000623	CcSEcCtD
Apixaban—Rash—Carbamazepine—epilepsy syndrome	7.51e-05	0.000617	CcSEcCtD
Apixaban—Dermatitis—Carbamazepine—epilepsy syndrome	7.5e-05	0.000616	CcSEcCtD
Apixaban—Nausea—Clonazepam—epilepsy syndrome	7.46e-05	0.000613	CcSEcCtD
Apixaban—Shock—Gabapentin—epilepsy syndrome	7.46e-05	0.000613	CcSEcCtD
Apixaban—Nervous system disorder—Gabapentin—epilepsy syndrome	7.43e-05	0.000611	CcSEcCtD
Apixaban—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.42e-05	0.00061	CcSEcCtD
Apixaban—Nausea—Phenytoin—epilepsy syndrome	7.41e-05	0.000609	CcSEcCtD
Apixaban—Nausea—Oxcarbazepine—epilepsy syndrome	7.37e-05	0.000606	CcSEcCtD
Apixaban—Skin disorder—Gabapentin—epilepsy syndrome	7.36e-05	0.000605	CcSEcCtD
Apixaban—Rash—Lamotrigine—epilepsy syndrome	7.25e-05	0.000596	CcSEcCtD
Apixaban—Dermatitis—Lamotrigine—epilepsy syndrome	7.25e-05	0.000596	CcSEcCtD
Apixaban—Anaemia—Topiramate—epilepsy syndrome	7.22e-05	0.000594	CcSEcCtD
Apixaban—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.14e-05	0.000587	CcSEcCtD
Apixaban—Hypotension—Gabapentin—epilepsy syndrome	7.08e-05	0.000582	CcSEcCtD
Apixaban—Nausea—Carbamazepine—epilepsy syndrome	7.07e-05	0.000581	CcSEcCtD
Apixaban—Syncope—Topiramate—epilepsy syndrome	7.01e-05	0.000576	CcSEcCtD
Apixaban—Loss of consciousness—Topiramate—epilepsy syndrome	6.87e-05	0.000564	CcSEcCtD
Apixaban—Nausea—Lamotrigine—epilepsy syndrome	6.83e-05	0.000562	CcSEcCtD
Apixaban—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.74e-05	0.000554	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.61e-05	0.000543	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.54e-05	0.000538	CcSEcCtD
Apixaban—Shock—Topiramate—epilepsy syndrome	6.27e-05	0.000516	CcSEcCtD
Apixaban—Nervous system disorder—Topiramate—epilepsy syndrome	6.25e-05	0.000514	CcSEcCtD
Apixaban—Thrombocytopenia—Topiramate—epilepsy syndrome	6.24e-05	0.000513	CcSEcCtD
Apixaban—Skin disorder—Topiramate—epilepsy syndrome	6.19e-05	0.000509	CcSEcCtD
Apixaban—Hypersensitivity—Pregabalin—epilepsy syndrome	6.09e-05	0.000501	CcSEcCtD
Apixaban—Dizziness—Valproic Acid—epilepsy syndrome	6.05e-05	0.000497	CcSEcCtD
Apixaban—Hypotension—Topiramate—epilepsy syndrome	5.96e-05	0.00049	CcSEcCtD
Apixaban—Rash—Valproic Acid—epilepsy syndrome	5.76e-05	0.000474	CcSEcCtD
Apixaban—Dermatitis—Valproic Acid—epilepsy syndrome	5.76e-05	0.000473	CcSEcCtD
Apixaban—Hypersensitivity—Gabapentin—epilepsy syndrome	5.58e-05	0.000459	CcSEcCtD
Apixaban—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.51e-05	0.000453	CcSEcCtD
Apixaban—Dizziness—Pregabalin—epilepsy syndrome	5.47e-05	0.000449	CcSEcCtD
Apixaban—Nausea—Valproic Acid—epilepsy syndrome	5.43e-05	0.000446	CcSEcCtD
Apixaban—Rash—Pregabalin—epilepsy syndrome	5.21e-05	0.000428	CcSEcCtD
Apixaban—Dermatitis—Pregabalin—epilepsy syndrome	5.21e-05	0.000428	CcSEcCtD
Apixaban—Dizziness—Gabapentin—epilepsy syndrome	5.01e-05	0.000412	CcSEcCtD
Apixaban—Nausea—Pregabalin—epilepsy syndrome	4.91e-05	0.000404	CcSEcCtD
Apixaban—Rash—Gabapentin—epilepsy syndrome	4.78e-05	0.000393	CcSEcCtD
Apixaban—Dermatitis—Gabapentin—epilepsy syndrome	4.77e-05	0.000392	CcSEcCtD
Apixaban—Hypersensitivity—Topiramate—epilepsy syndrome	4.7e-05	0.000386	CcSEcCtD
Apixaban—Nausea—Gabapentin—epilepsy syndrome	4.5e-05	0.00037	CcSEcCtD
Apixaban—Dizziness—Topiramate—epilepsy syndrome	4.22e-05	0.000347	CcSEcCtD
Apixaban—Rash—Topiramate—epilepsy syndrome	4.02e-05	0.00033	CcSEcCtD
Apixaban—Dermatitis—Topiramate—epilepsy syndrome	4.02e-05	0.00033	CcSEcCtD
Apixaban—Nausea—Topiramate—epilepsy syndrome	3.79e-05	0.000311	CcSEcCtD
Apixaban—CYP2C8—Metabolism—AQP1—epilepsy syndrome	7.27e-06	0.000142	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.25e-06	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.23e-06	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.23e-06	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.2e-06	0.00014	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.2e-06	0.00014	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	7.19e-06	0.00014	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—BCHE—epilepsy syndrome	7.16e-06	0.00014	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	7.15e-06	0.000139	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.11e-06	0.000139	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.1e-06	0.000138	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.1e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.06e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.06e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.98e-06	0.000136	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	6.97e-06	0.000136	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.94e-06	0.000135	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.93e-06	0.000135	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.91e-06	0.000135	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	6.83e-06	0.000133	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.79e-06	0.000132	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.77e-06	0.000132	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.75e-06	0.000132	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PLCB1—epilepsy syndrome	6.75e-06	0.000132	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TH—epilepsy syndrome	6.73e-06	0.000131	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.68e-06	0.00013	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.67e-06	0.00013	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.64e-06	0.000129	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	6.57e-06	0.000128	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	6.57e-06	0.000128	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.52e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.52e-06	0.000127	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.49e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.49e-06	0.000126	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.48e-06	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.44e-06	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.44e-06	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.44e-06	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.44e-06	0.000126	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.44e-06	0.000126	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.42e-06	0.000125	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.33e-06	0.000123	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.32e-06	0.000123	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.32e-06	0.000123	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.23e-06	0.000121	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	6.19e-06	0.000121	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.12e-06	0.000119	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.09e-06	0.000119	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.03e-06	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.03e-06	0.000118	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	6.03e-06	0.000118	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6e-06	0.000117	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	5.99e-06	0.000117	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.92e-06	0.000115	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.9e-06	0.000115	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.89e-06	0.000115	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.89e-06	0.000115	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.89e-06	0.000115	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.87e-06	0.000114	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.87e-06	0.000114	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.79e-06	0.000113	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.78e-06	0.000113	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.73e-06	0.000112	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.73e-06	0.000112	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.68e-06	0.000111	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.67e-06	0.000111	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.67e-06	0.000111	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HMOX1—epilepsy syndrome	5.62e-06	0.000109	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.57e-06	0.000109	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CAT—epilepsy syndrome	5.54e-06	0.000108	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.48e-06	0.000107	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.48e-06	0.000107	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.46e-06	0.000107	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.41e-06	0.000105	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.39e-06	0.000105	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	5.36e-06	0.000104	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.35e-06	0.000104	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.35e-06	0.000104	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.35e-06	0.000104	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	5.22e-06	0.000102	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.21e-06	0.000102	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	5.19e-06	0.000101	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.15e-06	0.0001	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.15e-06	0.0001	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	5.15e-06	0.0001	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—BCHE—epilepsy syndrome	5.13e-06	0.0001	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.06e-06	9.86e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GPX1—epilepsy syndrome	5.01e-06	9.77e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.01e-06	9.76e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.98e-06	9.71e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.89e-06	9.54e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.88e-06	9.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.88e-06	9.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.88e-06	9.52e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.86e-06	9.47e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.84e-06	9.43e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TH—epilepsy syndrome	4.82e-06	9.4e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.78e-06	9.33e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.7e-06	9.16e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.68e-06	9.13e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.67e-06	9.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.66e-06	9.08e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.66e-06	9.08e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.63e-06	9.03e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.6e-06	8.97e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.57e-06	8.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.57e-06	8.91e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.56e-06	8.88e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.55e-06	8.87e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.52e-06	8.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.46e-06	8.7e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.46e-06	8.69e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.44e-06	8.66e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AGT—epilepsy syndrome	4.39e-06	8.57e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.38e-06	8.53e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.36e-06	8.5e-05	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.31e-06	8.4e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOE—epilepsy syndrome	4.3e-06	8.39e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.3e-06	8.38e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.26e-06	8.3e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.25e-06	8.29e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	4.24e-06	8.26e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.22e-06	8.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.19e-06	8.18e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.19e-06	8.18e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	4.19e-06	8.17e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.18e-06	8.15e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TH—epilepsy syndrome	4.18e-06	8.14e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.17e-06	8.13e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.11e-06	8.01e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.08e-06	7.96e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.02e-06	7.84e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.02e-06	7.84e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.98e-06	7.76e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.97e-06	7.74e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.96e-06	7.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.9e-06	7.61e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.89e-06	7.59e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.88e-06	7.57e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.87e-06	7.54e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.86e-06	7.53e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.82e-06	7.45e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.81e-06	7.43e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.78e-06	7.37e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.74e-06	7.29e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.73e-06	7.27e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TH—epilepsy syndrome	3.73e-06	7.27e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—POMC—epilepsy syndrome	3.7e-06	7.21e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.69e-06	7.2e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—epilepsy syndrome	3.69e-06	7.18e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.67e-06	7.15e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.65e-06	7.12e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TH—epilepsy syndrome	3.64e-06	7.09e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.63e-06	7.08e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.63e-06	7.08e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.61e-06	7.05e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.61e-06	7.04e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.59e-06	7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.58e-06	6.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.53e-06	6.88e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.53e-06	6.88e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.48e-06	6.79e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.45e-06	6.72e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.44e-06	6.7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.41e-06	6.65e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TH—epilepsy syndrome	3.4e-06	6.62e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—epilepsy syndrome	3.37e-06	6.57e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.35e-06	6.52e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.34e-06	6.52e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.27e-06	6.37e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.26e-06	6.35e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.15e-06	6.14e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.11e-06	6.06e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.11e-06	6.06e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.1e-06	6.05e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.09e-06	6.02e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.08e-06	6.01e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.07e-06	5.98e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.04e-06	5.92e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAT—epilepsy syndrome	3e-06	5.84e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.99e-06	5.82e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.95e-06	5.75e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.95e-06	5.74e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.91e-06	5.68e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TH—epilepsy syndrome	2.9e-06	5.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.88e-06	5.61e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.86e-06	5.57e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.84e-06	5.53e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.8e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.8e-06	5.46e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.79e-06	5.43e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.78e-06	5.41e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.73e-06	5.32e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.72e-06	5.31e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.71e-06	5.28e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.67e-06	5.21e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.65e-06	5.17e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.53e-06	4.93e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.51e-06	4.9e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.43e-06	4.74e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.42e-06	4.72e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.42e-06	4.71e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.39e-06	4.67e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.39e-06	4.66e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.38e-06	4.65e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.38e-06	4.65e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AGT—epilepsy syndrome	2.38e-06	4.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—epilepsy syndrome	2.33e-06	4.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.33e-06	4.53e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.29e-06	4.47e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.27e-06	4.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.25e-06	4.38e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TH—epilepsy syndrome	2.24e-06	4.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.22e-06	4.33e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.17e-06	4.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.16e-06	4.22e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.11e-06	4.12e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.09e-06	4.08e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.05e-06	3.99e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—POMC—epilepsy syndrome	2e-06	3.9e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.9e-06	3.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.87e-06	3.65e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.87e-06	3.64e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.87e-06	3.64e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.86e-06	3.62e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.85e-06	3.6e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.83e-06	3.57e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—epilepsy syndrome	1.82e-06	3.55e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.8e-06	3.5e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.7e-06	3.32e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.67e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	3.19e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.6e-06	3.11e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.59e-06	3.11e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	2.9e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.48e-06	2.89e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.46e-06	2.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.46e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.43e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.27e-06	2.48e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.23e-06	2.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.12e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.06e-06	2.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.83e-07	1.92e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—epilepsy syndrome	9.2e-07	1.79e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.21e-07	1.6e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.02e-07	1.56e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.49e-07	1.46e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.4e-07	1.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.94e-07	9.63e-06	CbGpPWpGaD
